Skip to content

Product1 publisher2 min readPublished

Wandercraft routes its self-balancing exoskeleton through Medicare's custom-orthosis code

Wandercraft's Eve is cleared for adults with spinal cord injuries at any level who can work its controller. Getting one starts with a provider's prescription, a custom fitting, and a coverage decision on each individual claim.

The Product Desk · Product desk

Photograph accompanying Wandercraft routes its self-balancing exoskeleton through Medicare's custom-orthosis code
Photo: interestingengineering.com

What happened

  • Wandercraft, based in Paris, has started U.S. commercial sales of Eve, which it describes as the world's first FDA-cleared self-balancing personal exoskeleton for wheelchair users with spinal cord injuries.
  • Medicare covers qualifying personal exoskeletons as custom-fitted orthoses under HCPCS billing code K1007 for people who meet eligibility and medical necessity requirements.
  • Wandercraft has staffed an access team to handle benefits, documentation, reimbursement, financing and coordination with clinicians and payers on a user's behalf.

Compiled by The Product DeskSomething wrong?How this is made

Why it matters

  • constraint Coverage under the orthosis code is settled person by person. A clinic's placement rate depends on how fast its documentation moves, and a program that cannot staff appeals will not put many devices on many people.
  • decision Payers are being asked to fund a standing device for people whose wheelchairs they already pay for. The medical necessity case has to rest on hand use and reach.
  • capability An adult with a high cervical injury who can work a controller now sits inside the eligible population for a cleared self-balancing device. Earlier clearances drew a line by injury level.
  • exposure With no published price, a candidate who is denied coverage cannot see what the fallback costs before agreeing to an evaluation and a fitting.

The detail a test pilot leads with is having both hands. Wandercraft says Eve holds its own balance without crutches or a walker, crediting self-balancing technology powered by "physical AI", so a user can stand and move while reaching, carrying objects, preparing food or opening doors [3][6]. "With Eve, being upright isn't just about standing. It's about having the freedom to use my hands, move through my home, and connect with people in a new way," said Caroline Laubach, a Wandercraft test pilot [12].

Medicare's cover for qualifying personal exoskeletons under billing code K1007 is subject to individual coverage requirements [9]. Each claim is decided on its own, on documentation somebody has to assemble. Wandercraft also describes Eve as designed to complement, not replace, a wheelchair, for moments when a user chooses to be upright [10]. So the medical necessity argument is being made for a second mobility device on behalf of someone whose first one is already funded. The company did not disclose a price [14].

The chief executive put the emphasis in the same place. "That's why we built an infrastructure that supports people every step of the way, from evaluation and fitting to reimbursement, training, and ongoing service," said Matthieu Masselin, co-founder and CEO of Wandercraft [11]. The access team he is describing handles benefits, documentation, reimbursement, financing and coordination with clinicians and payers [8].

The clearance itself pushes work into the clinic. Eve is the first FDA-cleared device in its category without restrictions based on the neurological level of the injury. Eligibility turns instead on whether an adult can safely operate the controller and has none of the contraindications listed in the User Manual [4][5]. Wandercraft says that significantly expands the potential user population compared with previously cleared exoskeletons [13]. The screen is a functional one, so someone has to sit with a particular person and watch them work a particular controller.

For a rehab program deciding whether to add Eve to its evaluation menu, two questions settle the outcome. First, who performs the controller-safety evaluation, how long it takes, and whether that visit is billable. Second, how many denials the documentation staff absorbs before a first approval, and who eats the evaluation and fitting work when a determination comes back negative. Each device is custom-fit and manufactured for the individual after a provider's prescription, so the build queue and the payer queue both advance one case at a time [7].

What to watch

  • Whether Medicare contractors issue consistent K1007 determinations for Eve or deny in some regions and approve in others.
  • Whether Medicaid programs and commercial payers follow Medicare in covering personal exoskeletons as custom-fitted orthoses.
  • A published price, lease terms, or a stated wait time from prescription to delivery of a custom-built unit.
Loading claim ledger
Loading source directory links
Loading share composer
Loading topic controls
Loading related stories